Genome & Company

KOSDAQ · Healthcare · ₩206B

₩3,940+1.29%

Price

3730.0원

3900.0원

Jul 24, 26Oct 27, 26

What's this stock's score right now?

See its score for free — revenue and money flow, graded on one standard.

Quarterly Financials

RevenueOperating IncomeNet Income

9/'26

Revenue₩6.1B-2.5%

Operating Income-₩8.0B-0.3%

6/'26 vs prev quarter

Company Health

Market Cap₩206B

Operating Margin-119.3%

Short Volume 3.1% · as of 26.10.27

Among 34 바이오 peers

LowMedianHigh

PSR8.3xmedian 5.6x